Whitepaper – Protecting Critical Care Drugs
The trafficking of fake and altered drugs, including injectables, has reached epidemic levels in some parts of the world and is a growing problem in the United States.
According to the World Health Organization, 50% of drugs sold online are counterfeit.
What Brand Protection security measures do you have in place to protect your brand against these counterfeit drugs?
In this whitepaper you will learn:
Multi-layered solutions for positive identification
Importance of tracking products through the supply chain
Designs of a proactive, overarching anti-counterfeit strategy
